BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Orchid BioSciences 

4390 U.S. Route One

Princeton  New Jersey  08540  U.S.A.
Phone: 609-750-2200 Fax: 609-750-6400


SEARCH JOBS


Orchid BioSciences is a leading provider of DNA testing services for the human and animal identity markets. Orchid's strong market position in the forensic, paternity, immigration and food safety segments are built on the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark and GeneScreen brands that have been associated with exceptional quality, reliability and customer service since the mid-1980s. Orchid's acquisitions of leading DNA laboratories made it one of the world's first DNA testing service providers, and its history of pioneering innovative genetic analysis techniques have enabled the company to remain at the forefront as a technology and business leader, while also helping to advance the worldwide markets in which it operates.

Orchid has an established infrastructure of six accredited laboratories in the U.S. and U.K. that support its strategy of leadership in the identity DNA testing market, which the company believes represents the largest commercial opportunity in DNA testing existing today. Genetic differences between individuals and animals are most commonly identified by genotyping - the analysis of the unique genetic make-up of an organism. Over the last two decades, Orchid has developed a number of cutting-edge genotyping methods to create DNA profiles, including its proprietary techniques to analyze single nucleotide polymorphisms, or SNPs. SNPs are single base changes in DNA and represent the most abundant form of genetic variation. Orchid is leveraging its SNP technology and expertise in a number of areas where SNPs provide operational or competitive advantage.

Forensic DNA Testing
Orchid is one of the largest private DNA forensic testing service providers in the world, with an international network of four forensic testing laboratories in the U.S. and U.K. The company provides a full range of high quality, customized forensic DNA testing services, including identification of victims of accidents and disasters, criminal casework analysis and expert testimony, convicted offender DNA databasing, no-suspect casework for government law enforcement laboratories, and DNA testing and consultative services for the defense bar as well as for the prosecution. Orchid's services have been selected by major police departments and for many high profile criminal investigations. Orchid's forensic testing facilities have earned the highest accreditations in the industry. The company's three U.S. forensic testing facilities have all earned the prestigious ASCLD/LAB accreditation, a designation awarded to only a few private forensic DNA laboratories, and the company holds many additional accreditations and certifications in the U.S. and the U.K.

Orchid uses a variety of genetic analysis methods for its forensic DNA studies. The company has furthered its reputation as an innovator by collaborating with the New York City Medical Examiner's Office to conduct SNP-based genotyping tests to help identify the large number of 9/11 World Trade Center victims for whom other methods have failed. Orchid is also exploring the use of SNPs in other difficult cases involving degraded samples, and has contracts in place to fund the development of advanced techniques.

Paternity and Relationship DNA Testing
Orchid is one of the largest paternity testing providers in the world, with accredited laboratories in the U.S. and U.K. Orchid has analyzed millions of samples over the last two decades in its provision of DNA testing services to determine the parentage of a child and other familial relationships for both public and private sector customers. Orchid is the market leader for publicly funded paternity testing in North America, and the company has also recently increased its market share in the rapidly growing private paternity sector. Orchid also provides DNA testing services to many countries to confirm an inidividual's identity in both immigration and adoption cases, and recently launched IDSecure™, a service designed to ensure that workers on high-risk assignments can be accurately identified in the event of an emergency or accident.

Food Safety DNA Testing
Since 2001, Orchid has been a major supplier of genotyping services offered to U.K. sheep farmers under the government's National Scrapie Plan, the largest program in the world designed to help farmers breed sheep with reduced susceptibility to the mad cow-like prion disease scrapie. Orchid also provides scrapie tetsing services to a number of other European countries using its highly automated laboratory process with state-of-the-art robotics and integrated computer tracking and genotyping scoring systems. Building on its expertise in scrapie testing, Orchid is providing meat traceability DNA testing for Maple Leaf Foods, the largest pork producer in Western Canada. This program is designed to enable Canadian pork to be traced in a matter of hours from the store shelf back to the farm and even to the maternal sow. Orchid also currently provides a cattle traceability testing services to an undisclosed European country to help in the detection and prevention of fraud.

Background
Orchid was founded in 1995 as a spin-off of the Sarnoff Corporation and completed its IPO in May 2000. Since its inception, Orchid has successfully completed and integrated four acquisitions: Molecular Tool in 1998, GeneScreen in 1999, and both Lifecodes Corporation, including U.S.-based Cellmark Diagnostics, and U.K.-based Cellmark Diagnostics in 2001.

Management
Paul Kelly, M.D., Chief Executive Officer
Michael Spicer, Chief Financial Offinancial and Vice President, Finance
Julia Nuesch, Vice President, Human Resources
Robert Giles, Ph.D., Executive Director, US Operations
Chris Smith, Executive Director, Orchid GeneScreen
Mark Stolorow, Executive Director, Orchid Cellmark
Graham Vitty, Managing Director, Orchid Europe

Investor and Media Inquiries
Tracy Henrikson, Executive Director of Corporate Communications
(609) 750-2221 or thenrikson@orchid.com

Last Updated: 09-21-04


 Key Statistics


Email: mail@orchid.com
Ownership: Public

Web Site: Orchid BioSciences
Employees: 425 Worldwide
Symbol: ORCH
 





Collaborations

Maple Leaf Foods  In 2004, Orchid established a collaboration with Maple Leaf Foods in food traceability. Orchid is providing assay development and DNA testing services for Maple Leaf's pork traceability program.





 Company News
Orchid Cellmark To Present At The Rodman And Renshaw Annual Healthcare Conference 11/4/2005 11:40:34 AM
Orchid BioSciences, Inc. (ORCH) Proposes Changing Its Name To Orchid Cellmark Inc.10/19/2005 5:13:17 PM
Orchid BioSciences, Inc. (ORCH) To Announce First Quarter 2005 Financial Results On April 28, 200510/19/2005 5:13:04 PM
Orchid BioSciences, Inc. (ORCH) Launches Scrapie Susceptibility Testing Kit10/19/2005 5:12:59 PM
Orchid BioSciences, Inc. (ORCH) Reports Fourth Quarter And Full Year 2004 Financial Results10/19/2005 5:12:59 PM
Alpharma Inc. (ALO) Announces Development And Manufacturing Agreement With Orchid Chemicals & Pharmaceuticals Ltd.10/19/2005 5:12:49 PM
Orchid BioSciences, Inc. (ORCH) To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference10/19/2005 5:12:48 PM
Orchid BioSciences, Inc. (ORCH) To Announce Fourth Quarter And Full Year 2004 Financial Results On March 10, 200510/19/2005 5:12:45 PM
Orchid BioSciences, Inc. (ORCH) To Present At The UBS Global Healthcare Services Conference10/19/2005 5:12:44 PM
Orchid BioSciences, Inc. (ORCH) Cellmark To Distribute Innovative DNA-Based Law Enforcement Tool10/19/2005 5:12:28 PM
1234567